CEO Rohan Greenland shares an enormous thank you to everyone who took part in or supported this year’s iconic May 50K, and outlines MS Australia’s advocacy priorities in the post-election…
New clinical trial results show that tolebrutinib reduces the risk of disability progression in non-relapsing secondary progressive MS and is as effective as teriflunomide in relapsing MS….
This National Volunteer Week, we are celebrating the contributions of the members of MS Australia’s Lived Experience Expert Panel, who share why they’re so passionate about volunteering….
The Pharmaceutical Benefits Advisory Committee (PBAC) will consider adding ocrelizumab (Ocrevus®) via subcutaneous delivery to the PBS for relapsing remitting MS….
As Australians head toward the 2025 Federal Election, The Raw Nerve, MS Australia’s official podcast, gathered leading experts to explore a crucial question: why should health be a top election…
MS Canada and MS Australia lead new global initiative into the prevention and ultra-early detection of MS
23 April 2025
A new international effort to prevent multiple sclerosis (MS) is officially underway, as researchers, clinicians, people living with MS, and MS organisations from around the world gather in Lisbon, Portugal,…
Researchers have discovered that genetic changes accumulate more rapidly in MS brain lesions than in non-lesion tissue, with distinct patterns emerging in the lesions….
A pilot study has found an existing online cognitive behavioural therapy (CBT) program from Germany is highly acceptable to people with multiple sclerosis (MS) in Australia and achieved reduced levels…
Luigi wanted his legacy to be one that made a difference. Through his generous bequest to MS Plus, he ensured that people living with multiple sclerosis would receive the support…